Literature DB >> 27604396

CD38 expression in paediatric leukaemia and lymphoma: implications for antibody targeted therapy.

Anne E Bras1, Auke Beishuizen2, Anton W Langerak1, Mojca Jongen-Lavrencic3, Jeroen G Te Marvelde1, Marry M van den Heuvel-Eibrink2, C Michel Zwaan2, Jacques J M van Dongen1, Vincent H J van der Velden1.   

Abstract

Entities:  

Keywords:  CD38; immunophenotyping; leukaemia; lymphoma; paediatric

Mesh：

Substances：

Year:  2016        PMID： 27604396     DOI： 10.1111/bjh.14310

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

Review 1.  CAR T cells for other pediatric non-B-cell hematologic malignancies.

Authors:  Adam J Lamble; Rebecca Gardner
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 2.  Recent Advances in the Management of Acute Lymphoblastic Leukaemia.

Authors:  Katharine A Hodby; David I Marks
Journal:  Curr Treat Options Oncol       Date:  2020-02-20

3.  Flow cytometric evaluation of CD38 expression levels in the newly diagnosed T-cell acute lymphoblastic leukemia and the effect of chemotherapy on its expression in measurable residual disease, refractory disease and relapsed disease: an implication for anti-CD38 immunotherapy.

Authors:  Prashant Ramesh Tembhare; Harshini Sriram; Twinkle Khanka; Gaurav Chatterjee; Devasis Panda; Sitaram Ghogale; Yajamanam Badrinath; Nilesh Deshpande; Nikhil V Patkar; Gaurav Narula; Bhausaheb Bagal; Hasmukh Jain; Manju Sengar; Navin Khattry; Shripad Banavali; Sumeet Gujral; Papagudi G Subramanian
Journal:  J Immunother Cancer       Date:  2020-05       Impact factor: 13.751

4.  A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma.

Authors:  Yifei Liu; Tingting Bian; Yanlin Zhang; Yuanyuan Zheng; Jianguo Zhang; Xiaoge Zhou; Jianlan Xie
Journal:  Diagn Pathol       Date:  2019-09-04       Impact factor: 2.644

Review 5.  The role of CD38 in HIV infection.

Authors:  Liqi Lu; Jie Wang; Qian Yang; Xiuqiao Xie; Yuanshuai Huang
Journal:  AIDS Res Ther       Date:  2021-04-05       Impact factor: 2.250

Review 6.  Antigen Loss after Targeted Immunotherapy in Hematological Malignancies.

Authors:  Ting Zhou; Hao-Wei Wang
Journal:  Clin Lab Med       Date:  2021-07-02       Impact factor: 2.172

7.  Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study.

Authors:  Nienke Brouwer; Sergio Matarraz; Stefan Nierkens; Mattias Hofmans; Michaela Nováková; Elaine Sobral da Costa; Paula Fernandez; Anne E Bras; Fabiana Vieira de Mello; Ester Mejstrikova; Jan Philippé; Georgiana Emilia Grigore; Carlos E Pedreira; Jacques J M van Dongen; Alberto Orfao; Vincent H J van der Velden
Journal:  Cancers (Basel)       Date:  2022-03-21       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.